Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 1M | 658,000 | — | — |
| Cost of revenue | 4M | 1M | — | — |
| Gross profit | −3M | −580,000 | — | — |
| Research and development | 2M | 6M | 5M | 6M |
| Selling, general and administrative | 3M | 3M | 5M | 5M |
| Operating expenses | 5M | 8M | 10M | 11M |
| Operating income | −8M | −9M | −10M | −11M |
| Net income | −8M | 5M | −7M | −6M |
| Earnings per share | — | — | 0.00 | 0.01 |
| Earnings per share, diluted | — | — | 0.00 | 0.01 |
| Weighted average shares, diluted | 9.34B | 3.23B | 1.56B | 754M |
| Metric | 19/08/2026 | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 2M | 2M | 5M | 14M | 18M |
| Receivables | — | — | 73,000 | 83,000 |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −6M | −6M | −9M | −7M |
| Depreciation and amortisation | 1M | 2M | 514,000 | 562,000 |
| Share-based compensation | 303,000 | 682,000 | 1M | 2M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| Current assets | — | — | 2M | 2M | 5M | — | — |
| Property, plant and equipment | — | — | 8M | 9M | 11M | — | — |
| Total assets | — | — | 12M | 13M | 17M | — | — |
| Current liabilities | — | — | 2M | 2M | 2M | — | — |
| Equity | — | — | 8M | 10M | −5M | −2M | 982,000 |
| Shares outstanding | — | — | 13.87B | 3.41B | 1.86B | — | — |
| Shares issued | — | — | 13.87B | 3.41B | 1.86B | — | — |
| 24,000 |
| 12,000 |
| 637,000 |
| 836,000 |
| Investing cash flow | −24,000 | −12,000 | −637,000 | −836,000 |
| Financing cash flow | 6M | 3M | 1M | 7M |